Position in NTRA
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$27,320,084
+$6,076,747 QoQ
Shares Held
100,645
-5.3% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#128
of 844 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Sterling Capital Management LLC holds $57,450,565 across 31 Diagnostics & Research names. NTRA ranks #1 (47.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
This page
|
100,645 | $27,320,084 | |
| 2 | DHR |
Danaher Corp /De/
|
66,320 | $12,632,632 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
5,328 | $2,671,246 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
3,902 | $2,054,168 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
7,719 | $1,491,465 | |
| 6 | ILMN |
Illumina, Inc.
|
7,216 | $1,268,789 | |
| 7 | DGX |
Quest Diagnostics Inc
|
5,769 | $1,222,739 | |
| 8 | RVTY |
Revvity, Inc.
|
10,975 | $1,221,078 |
All Filings in NTRA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,320,084 | 100,645 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $21,243,337 | 106,222 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $16,321,975 | 71,247 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,305,466 | 8,110 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,969,627 | 17,578 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,512,290 | 17,766 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,318,620 | 14,647 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $262,405 | 2,067 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||